atomoxetine hydrochloride has been researched along with Depression in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robbins, TW | 1 |
| Ahmad, I; Chawarski, MC; Chooi, WT; M Yasin, MA; Schottenfeld, RS; Sofuoglu, M; Syed Jaapar, SZ; Vicknasingam, BK; Zaharim, NM | 1 |
| Sharma, A | 1 |
| Carson, RE; Ding, YS; Gallezot, JD; Huang, Y; Laruelle, M; Lin, SF; McCarthy, TJ; Nabulsi, N; Naganawa, M; Ropchan, J; Weinzimmer, D | 1 |
| Besag, FM | 1 |
| Adler, L; Amsterdam, J; Dunner, D; Feldman, P; Marchant, B; Michelson, D; Nierenberg, A; Reimherr, F; Schatzberg, A; Williams, D; Zhang, S | 1 |
| Kjar, D; Rajab, MH; Ripperger-Suhler, J; Scott, NG | 1 |
| Colcher, A; Duda, JE; Horn, SS; Hurtig, HI; Mamikonyan, E; Mavandadi, S; Nazem, S; Siderowf, AD; Stern, MB; Ten Have, TR; Weintraub, D | 1 |
| Araki, H; Kawasaki, H; Suemaru, K; Takechi, K | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Bernauer, MJ; Farr, AM; Haynes, VS; Kelsey, D; Molife, C | 1 |
| Berigan, T | 1 |
| Blier, P | 1 |
| Faries, D; Kelsey, D; Kendrick, K; Michelson, D; Sallee, FR; Spencer, T; Wernicke, J | 1 |
| Preti, A | 1 |
3 review(s) available for atomoxetine hydrochloride and Depression
| Article | Year |
|---|---|
Cross-species studies of cognition relevant to drug discovery: a translational approach.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognition; Depression; Drug Discovery; Humans; Obsessive-Compulsive Disorder; Reaction Time; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical | 2017 |
Update on Common Psychiatric Medications for Children.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
Tomoxetine (Eli Lilly & Co).
Topics: Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Depression; Drug Industry; Drugs, Investigational; Humans; Propylamines; Structure-Activity Relationship; Treatment Outcome | 2002 |
4 trial(s) available for atomoxetine hydrochloride and Depression
| Article | Year |
|---|---|
Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine-Related Disorders; Atomoxetine Hydrochloride; Behavior Therapy; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Depression; Double-Blind Method; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Treatment Outcome; Young Adult | 2018 |
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Propylamines; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Sertraline; Statistics, Nonparametric | 2010 |
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Aged; Atomoxetine Hydrochloride; Cognition Disorders; Comorbidity; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Propylamines; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Wake Disorders; Time Factors; Treatment Outcome | 2010 |
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.
Topics: Adolescent; Age Factors; Algorithms; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Depression; Dose-Response Relationship, Drug; Drugs, Investigational; Female; Humans; Male; Propylamines | 2001 |
8 other study(ies) available for atomoxetine hydrochloride and Depression
| Article | Year |
|---|---|
Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Depression; Dose-Response Relationship, Drug; Macaca mulatta; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Propylamines; Serotonin Plasma Membrane Transport Proteins; Tissue Distribution | 2014 |
Is suicidality serious?
Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Antidepressive Agents; Atomoxetine Hydrochloride; Depression; Humans; Patient Education as Topic; Propylamines; Risk Assessment; Risk Factors; Suicide; Terminology as Topic | 2009 |
Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Depression; Drug Therapy, Combination; Electronic Health Records; Female; Humans; Male; Propylamines; Retrospective Studies; Treatment Outcome | 2010 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; Depression; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Propylamines; Seizures; Swimming | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Depression; Drug Therapy, Combination; Female; Humans; Insurance, Health; Male; Medicaid; Practice Patterns, Physicians'; Propylamines; Retrospective Studies; United States | 2012 |
The use of atomoxetine adjunctively in fibromyalgia syndrome.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depression; Female; Fibromyalgia; Humans; Propylamines; Sertraline | 2004 |
Psychopharmacology for the clinician. Treating depression with selective norepinephrine reuptake inhibitors.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Depression; Humans; Male; Middle Aged; Propylamines; Psychiatric Status Rating Scales | 2006 |